Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 2
2003 3
2004 4
2005 3
2006 2
2007 9
2008 5
2009 13
2010 10
2011 8
2012 14
2013 10
2014 8
2015 5
2016 9
2017 9
2018 7
2019 3
2020 5
2021 5
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
Diabetes in Asia.
Hayashino Y, Fukuhara S. Hayashino Y, et al. Lancet. 2010 Mar 20;375(9719):981-2. doi: 10.1016/S0140-6736(10)60434-5. Lancet. 2010. PMID: 20304238 No abstract available.
The organization and financing of end-stage renal disease treatment in Japan.
Fukuhara S, Yamazaki C, Hayashino Y, Higashi T, Eichleay MA, Akiba T, Akizawa T, Saito A, Port FK, Kurokawa K. Fukuhara S, et al. Among authors: hayashino y. Int J Health Care Finance Econ. 2007 Sep;7(2-3):217-31. doi: 10.1007/s10754-007-9017-8. Int J Health Care Finance Econ. 2007. PMID: 17690980 Review.
Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type C.
Yamada Y, Ishitsuka Y, Kondo Y, Nakahara S, Nishiyama A, Takeo T, Nakagata N, Motoyama K, Higashi T, Arima H, Kamei S, Shuto T, Kai H, Hayashino Y, Sugita M, Kikuchi T, Hirata F, Miwa T, Takeda H, Orita Y, Seki T, Ohta T, Kurauchi Y, Katsuki H, Matsuo M, Higaki K, Ohno K, Matsumoto S, Era T, Irie T. Yamada Y, et al. Among authors: hayashino y. Br J Pharmacol. 2021 Jul;178(13):2727-2746. doi: 10.1111/bph.15464. Epub 2021 May 12. Br J Pharmacol. 2021. PMID: 33782944
117 results